Home

Steven E Voskuil

CIK 1622634 · SVP, Chief Financial Officer · last filed 2026-08-06

Steven E Voskuil is a SVP, Chief Financial Officer who has filed 110 SEC Form 4 insider transactions across 4 companies since 2014. The most recent filing shows the insider sold $171.0K of HSY on Aug 6, 2026. Across all open-market trades the lifetime net is −$8.9M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $9.6M across reported positions. 86 SEC filings were submitted jointly with CO HERSHEY.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$9.60M

Companies

4

Total Filings

110

Lifetime Open-Market Net

-$8.91M

Filer Profile

Reported Address
19 E. CHOCOLATE AVENUE
HERSHEY, PA 17033
Related Filers
CO HERSHEY — 86 joint filings, latest 2026-08-06
Bath & Body Works, Inc. — 7 joint filings, latest 2026-06-15
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
HSY SVP, Chief Financial Officer 52,245 $170.42 $8.90M -$9.33M 55 2026-08-06
BBWI Director 41,895 $16.72 $700.5K $300.7K 6 2026-06-15
AVANOS MEDICAL, INC. (AVNS) Delisted SVP, Chief Financial Officer 31,479 $24.99 $786.7K $87.5K 4 2019-05-07
AVANOS MEDICAL, INC. (HYH) Delisted SVP, Chief Financial Officer 20,238 — — $30.0K 14 2018-05-04

Recent Filings

110 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-06 HSY Sell (S) −950 -$171.0K EDGAR
2026-08-06 HSY Sell (S) −950 -$171.0K EDGAR
2026-08-05 HSY Notice (144) −950 -$171.0K EDGAR
2026-07-21 HSY Sell (S) −1,500 -$255.0K EDGAR
2026-07-20 HSY Notice (144) −1,500 -$255.0K EDGAR
2026-06-22 HSY Sell (S) −1,500 -$260.1K EDGAR
2026-06-18 HSY Notice (144) −1,500 -$260.1K EDGAR
2026-06-15 BBWI Grant (A) +7,970 $0 EDGAR
2026-05-19 HSY Sell (S) −1,500 -$279.4K EDGAR
2026-05-18 HSY Notice (144) −1,500 -$279.4K EDGAR
Showing 1–10 of 110
Page 1 of 11
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.